INDEX PHARM. AB AK B

Share · SE0008966295 · A2ATYC (XSTO)

Overview

No Price

Closing Price XSTO 29.10.2025: 40,90 SEK

29.10.2025 10:30

Current Prices from INDEX PHARM. AB AK B

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ STOCKHOLM AB	FLERIE.ST	SEK	29.10.2025 10:30	40,90 SEK	0,25 SEK +0,62 %

Company Profile for INDEX PHARM. AB AK B Share

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences in preclinical stage for the treatment of various immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.

Get up to date insights from finAgent about INDEX PHARM. AB AK B

Company Data

Name INDEX PHARM. AB AK B

Company InDex Pharmaceuticals Holding AB (publ)

Website https://www.indexpharma.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2ATYC

ISIN SE0008966295

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Jenny Sundqvist

Market Capitalization 4 Mrd.

Country Sweden

Currency SEK

Employees 0,0 T

Address Berzelius vAeg 13, 171 65 Solna

IPO Date 2016-10-11

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	FLERIE.ST
NASDAQ STOCKHOLM AB	INDEX.ST
Frankfurt	1NP.F

More Shares

Investors who hold INDEX PHARM. AB AK B also have the following shares in their portfolio:

ALB.1/AGG.H. 25/30 REGS Bond

LYXOR STOXX EUROPE 600 INDUSTRIAL GOODS & SERVICES UCITS ETF - ACC ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog